ALEXANDRIA, Va., Jan. 28 -- United States Patent no. 12,535,484, issued on Jan. 27, was assigned to Fred Hutchinson Cancer Center (Seattle).

"Autoantibodies and autoantibody-autoantigen complexes as biomarkers of small cell lung cancer" was invented by Paul Lampe (Seattle), Ashley McGarry Houghton (Seattle) and Kristin Lastwika (Seattle).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are high performance biomarkers and panel for small cell lung cancer (SCLC) early detection useful for identifying, diagnosing and treating SCLC patients at an early stage. The method of detecting and diagnosing small cell lung cancer (SCLC) includes contacting a sample from a subject suspected of being at-risk o...